Know better the speakers of TECBIO
Dr. Jerry Pommer – SAB Biotherapeutics – USA.

Sab Biotherapeutics

Lecture: "USA Regulatory Pathway for Human Polyclonal Antibody Therapies Derived from Transchromosomal (Tc) Bovine."
Dr, Jerry Pommer is Chief Compliance Officer VP Regulatory Compliance & Quality Assurance of SAB Therapeutics Company, headed on Sioux Falls, South Dakota, USA. SAB Therapeutics develops human polyclonal antibodies against diseases like Ebola and Zika, using transgenic bovines. Dr. Pommer has more than 30 years of experience in biosafety and animal disease, transgenic animal development, animal well fair and health regulation. Nowadays, he is responsible for the implementations and maintenance of high quality standard regarding to animal care, according to the American laws of FDA, USDA and NIH, besides maintenance of accreditation of AAALAC.

Date:Thursday – 7/20/2017
Time: 5:30 p.m. - 7:00p.m
Country: United States of America

United States of America

Dr.Simon Lillico

University of Edinburgh – Scotland

Lecture: "Editing Livestock Genomes"
Dr. Simon Lillico is a researcher of Roslin Institute, at University of Edinburgh, global known institute for Dolly, the sheep in 1997. He is B.S. in Biology/Zoology/Animal Biology, first class honors at University of Edinburgh, M.S. in Applied Parasitology and Medical Entomology at University of Liverpool, Ph.D. in African trypanosomes at Glasgow University, same institution of his post-doctoral research. Changing subjects, Dr. Simon entered to The Roslin Institute at the end of 2002 to work at an academic/industrial project to produce transgenic chicken, which expresses therapeutic proteins in eggs (Lillico et al, PNAS, 2007). Although challenging, this work was really grateful and it gave experience to him in lentiviral transgenesis. In 2007, he changed his research from chicken to bovines, sheep and pigs, using his experience with lentivirus to introduce transgenes to modulate human disease progression (Kostic, Lillico et al, PLoS One, 2013). The fast expansion of genome editing from 4 years to now has been changing unreachable genomes so far. Simon has been at the edge of editing applications to create disease-resistant animals or to generate more precise human disease models. Dr. Simon has experience with TALENs (Lillico et al, Sci. Rep., 2013), ZFNs (Lillico et al, Sci. Rep., 2016) and more recently CRISPR/Cas9 (Burkard et al., PLoS Pathog., 2017) through a huge net of collaborations involving tool key-developers (Sangamo), research and development companies in the livestock field (Recombinetics Inc.) and international academic institutions.

Date: Saturday – 7/22/2017
Time: 4:30 - 5:30 p.m.
Country: Scotland


Dr. Irina Polejaeva

Utah State University – USA

Lecture: "Use of animal cloning in biotechnology"
Dr. Irina Polejaeva is a professor and researcher of Utah State University, located at Logan, USA. She is one of the pioneers of Somatic cell nuclear transfer (SCNT). Her work led to the generation of the world’s first cloned pigs by SCNT and the birth of the world’s first 1, 3-galactosyltransferase deficient pigs. Dr. Polejaeva is Chief editor of PLOS one journal, and her interests are animal cloning, egg activating studies and embryonic development after cloning, manipulating genes from animal genome to model development for human disease studies.

Data:Friday – 7/21/2017
Horário:9:30 - 10:30 a.m.
País: United Stated of America

United Stated of America

Dr. Hua Wu

SAB Biotherapeutics – USA

Lecture: "Using fully human antibodies from TC bovine to fight infectious diseases"
Dr. Hua Wu is a senior scientist and Vice-President of Vaccine and Antibody Development at SAB Biotherapeutics Company, headed on Sioux Falls, South Dakota, USA. Dr. Wu directs the development of vaccines and immunization programs to produce highly potent fully human therapeutic antibodies from Transchromosomal (Tc) Bovine. SAB Biotherapeutics has polyclonal antibodies in clinical phase in the US, conducted by the FDA. Dr. Wu conducted her post-doctoral research at Harvard Medical School. She received her Ph.D. in molecular and cellular biology from the University of Massachusetts, and her M.S. in biochemistry and her B.S. in molecular biology from Jilin University in China.

Data: Friday – 7/21/2017
Horário: 8:30 - 9:30 a.m.
País: United States of America

United States of America

Dr. Jorge Roberto Toledo

University of Concepción – Chile

Lecture: "Adenoviral vector as simplified methodology for glycosylation modification and the analysis of the expression of biopharmaceuticals in mammary gland"
Dr. Jorge Roberto Toledo is an Associate Professor and Director of Biotechnology and Biopharmaceuticals Laboratory at University of Concepción, Chile. Dr. Toledo owns a patent for the production of recombinant proteins in the mammary gland of non-transgenic animals using adenoviral vector, and he develops studies regarding to growth hormone, erythropoietin, VIII factor coagulation, follicle stimulating hormone, among others. Dr. Toledo is an expert on different platforms for biopharmaceuticals production with experience in CHO cells, Pichia pastoris, Escherichia coli, chicken egg and goat mammary gland. Dr. Toledo is also the director of CBB, a technology-based company, which works on the development of recombinant proteins to vets and human market.

Date: Friday – 7/21/2017
Time: 3:00 - 4:00 p.m
Country: Chile


Dr. Zhongde Wang

Utah State University-USA

Lecture: "Triple Immunoglobulin Gene Knockout and human IgG to produce Transchromosomic Cattle"
Dr. Zhongde Wang is a professor and researcher of Utah State University, located at Logan, USA. He received his Ph.D. in Cellular and Molecular Biology from University of Massachusetts. He has experience with molecular biology, using TALENs and CRISPR/Cas9 for animal gene targeting. He was involved in the production of Transchromosomic cloned cattles, which produce human polyclonal antibodies. His pipelines include animal transgenesis, stem cell epigenetics and assisted-reproduction technologies.

Date: Friday – 7/21/2017
Time: 11:00 - 12:00 a.m.
Country: United States of America

Estados Unidos

Dr. Ana Maria Moro

Butantan Institute – Brazil

Lecture: "Monoclonal antibodies production in mammalian cells”
Dr. Ana Maria Moro is a researcher of Butantan Institute, director of Biopharmaceuticals in Animal Cells Laboratory and Professor of Biotechnology and Immunology Graduate Program of University of São Paulo. She has experience in Biotechnology, Applied Immunology and Molecular Biology, working on these fields: monoclonal antibodies, humanized monoclonal antibodies, human therapeutic antibodies, cell lineage generation, cell culture, cellular metabolism, process development and bioreactors.

Date: Saturday – 7/22/2017
Time: 8:30 - 9:30h a.m.
Country: Brazil


Dr. José Fernando Perez

Recepta Biopharma- Brazil

Lecture: "Innovation on oncology: Immunotherapy "
Dr. José Fernando Perez is the president of Recepta Biopharma, a human health biotechnology company. Recepta is dedicated to research and development of new pharmaceuticals used on cancer treatment, and it was the first Brazilian company to conduct phase II clinical trials with monoclonal antibodies on cancer treatment with register on ANVISA and FDA. Dr. Perez was scientific Director of FAPESP for more than 11 years, responsible for the conception and launching of important scientific programs, such as Genome and Technological Innovation in Small Companies (PIPE). He has international acknowledge including citations on Nature (Editorial, June 2000), New York Times (May 1st 2001) and The Economist (July 2000).

Date: Saturday – 7/22/2017
Time: 9:30 - 10:30 a.m.
Country: Brazil


Dr. Neemias Silva de Andrade

Agência Nacional de Vigilância Sanitária (ANVISA) -Brazil

Lecure: "Registration of Biologics in Brazil”
Dr. Neemias Silva de Andrade is a pharmacist, M.S. in Community Medicine and Specialist in Sanitary Vigilance and Regulation, his position on ANVISA nowadays. He is also a member of Evaluation and Management of Biologics Products, with 12 years of experience. He acts especially on these fields: Pharmaceuticals, Blood products, sanitary vigilance.

Date:Saturday – 7/22/2017
Time: 2:00 - 3:00 p.m.
Country: Brazil


Dr. Vinícius A. M. Ribeiro da Silva

Health Ministry – Brazil

Lecture: "Biopharmaceuticals Products of Interest to the Health Public System”
Bachelor in Law Science at Pontificia Catholic University of Parana and technologist of controlling constructions at SENAI-PR. Crier formed by the Finance Administration School, Ministry of Finance. He has worked onto more than 500 bidding processes as a crier, president, and team member of supporting and inspection contract. He has wise expertise on public purchases, administrative contracts, internal controlling and administrative processes. He won in 2013 and 2014 the “Best Practices in Administrative Contracts Inspection and Management Prize”. He is General Coordinator of Regulatory Subjects on Industrial Complex Department and Innovation in Health of Science, Technology and Strategic Supplies Secretary – Ministry of Health.

Date: Saturday – 7/22/2017
Time:3:00 - 4:00 p.m.
Country: Brazil


Dr. Nínive Aguiar Colonello Frattini

Ministry of Health – Brazil

Lecture: "Biopharmaceuticals Products of Interest to the Health Public System”
Ph.D. and M.S. in Science at São Paulo University. Dr. Nínive has studies on Functional Genomics and Cellular and Molecular Biology and Protein Engineering. Nowadays, she is a technologist of Public Politics Management in Health of The General Coordination of Regulatory Subjects, which belongs to the Industrial Complex Department and Innovation in Health of The Science, Technology and Strategic Supplies Secretary – Ministry of Health. She coordinates the creation and formulation of guidelines in health biosafety and promotes the integration of different corporation to Health Public System regarding to biosafety and marine Biotechnology issues.

Date: Saturday – 7/22/2017
Time: 3:00 - 4:00 p.m.
Country: Brazil


Dr. Gilvan Pessoa Furtado

Oswaldo Cruz Foundation (Fiocruz) – Brazil

Lecture: "Protein Engineering to Develop Biobetters”
Dr. Gilvan Pessoa Furtado is a researcher on Oswaldo Cruz Foundation in Ceara with interests in development of therapeutic antibodies. He is B.S. in Biochemistry at Federal University of Viçosa (2007), M.S. (2009), Ph.D. (2013) in Biochemistry and post-doctoral (2014) at Medical School of Ribeirão Preto. He has experience in Biochemistry and Molecular Biology, with emphasis on protein engineering and proteomics. He has worked with directed evolution of proteins, chimeric multifunctional enzymes, ligand prospection by phage display and large-scale proteomics.

Date: Friday – 7/21/2017
Time: 2:00 – 3:00 p.m.
Country: Brazil


Dr. Eridan Orlando Pereira

Greenbean Biotechnology, State University of Ceara – Brazil

Lecture: "Challenges to the production of recombinant proteins in plants of Brazilian Northeast "
Dr. Eridan Orlando Pereira is B.S. in Biology at Araraquara University Center (2002), M.S. in Biology (Genetics) at State University of Júlio de Mesquita Filho (2005), Ph.D. in Biology at University of Western Ontario (2013). He is Visitor Professor at State University of Ceara and Professor of RENORBIO, Partner-Collaborator at Greenbean Biotechnology and Collaborator at International Society of Plant Molecular Farming. Dr. Eridan has large experience in Biochemistry with emphasis on Molecular Biology, working on these subjects: Dengue, Zika, Chikungunya and production of recombinant proteins in plants.

Data: Friday – 7/21/2017
Horário: 4:30 - 5:30 p.m.
País: Brazil


Dr. Leonardo Tondello Martins

University of Fortaleza – Brazil

Lecture: "Biopharmaceuticals Production on transgenic animal’s milk”
Dr. Leonardo Tondello Martins is B.S. in Veterinary at State University of Santa Catarina (UDESC), M.S. in Animal Science at State University of Santa Catarina with emphasis on Fisiology of Reproduction and Ph.D. in Biotechnology at RENORBIO. Specialized at Florida University and Cornell University in reproduction and nutrition (2008-2010), nowadays he is professor and researcher of University of Fortaleza (UNIFOR), has experience on embryology, cell biology, cellular therapy with stem cells and works on transgenesis to biopharmaceuticals production, using animal platform, and developing genetically modified murine models to investigate diseases and pharmaceuticals. Co-founder of Fortgen Technologies, which works on 3 different fields: development of biopharmaceuticals and transferring technology to the market; in vitro fertilization and cellular therapy with stem cells.

Date: Saturday – 7/22/2017
Time: 11:00 - 12:00 a.m.
Country: Brazil